maclurin has been researched along with Prostatic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, JY; Jung, O; Lee, J; Lee, SY; Lee, YJ; Ryou, C; Son, J | 1 |
1 other study(ies) available for maclurin and Prostatic Neoplasms
Article | Year |
---|---|
Maclurin exerts anti-cancer effects on PC3 human prostate cancer cells via activation of p38 and inhibitions of JNK, FAK, AKT, and c-Myc signaling pathways.
Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Cell Movement; Extracellular Matrix; Focal Adhesion Kinase 1; Garcinia mangostana; Humans; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Signaling System; Morus; Oxidants; PC-3 Cells; Phenols; Phytotherapy; Plant Extracts; Plant Lectins; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc | 2018 |